Who
Gregory Gene Freitag
Director
Company insider
Files Form 4 as: Director, PDS Biotechnology; Director, ZyVersa Therapeutics; General Counsel, Axogen; Director, Pressure Biosciences.
In numbers
- Trades disclosed
- 133
- Buys
- 8
- Sells
- 13
- Bought
- $179K
- Sold
- $4.1M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 1 Jun 2010
- Last trade
- 12 Jan 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jan 2026filed 3 Mar 2026 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,876 at $0.00 | filing |
| 12 Jan 2026filed 3 Mar 2026 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,876 at $0.00 | filing |
| 11 Jul 2025filed 15 Jul 2025 | ZyVersa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,066 at $0.00 | filing |
| 11 Jun 2025filed 11 Jun 2025 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,700 at $0.00 | filing |
| 28 Feb 2025filed 3 Mar 2025 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code P | —15,060 | filing |
| 28 Feb 2025filed 3 Mar 2025 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Bought | $25K15,060 at $1.66 | filing |
| 24 Jun 2024filed 25 Jun 2024 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,904 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —11,904 at $0.00 | filing |
| 7 Mar 2024filed 8 Mar 2024 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $225K25,000 at $9.00 | filing |
| 1 Sep 2023filed 7 Sep 2023 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —20,436 at $0.00 | filing |
| 1 Sep 2023filed 7 Sep 2023 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —11,904 at $0.00 | filing |
| 14 Jul 2023filed 17 Jul 2023 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 1 Jun 2023filed 5 Jun 2023 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,459 at $0.00 | filing |
| 1 Jun 2023filed 5 Jun 2023 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $108K12,500 at $8.65 | filing |
| 1 Jun 2023filed 5 Jun 2023 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $258K29,480 at $8.74 | filing |
| 1 Jun 2023filed 5 Jun 2023 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —6,459 at $0.00 | filing |
| 24 May 2023filed 18 Jul 2024 | ZyVersa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —132 at $0.00 | filing |
| 23 May 2023filed 24 May 2023 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $26K2,828 at $9.17 | filing |
| 23 May 2023filed 24 May 2023 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $43K4,640 at $9.26 | filing |
News
Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)AXGN · tickerreport.com · 21 Oct 2026Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Gregory Gene Freitag; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.